Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Spetzler

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
The Journal of Molecular Diagnostics : JMD|September 25, 2021
Predicted Immunogenicity of CDK12 Biallelic Loss-of-Function Tumors Varies across Cancer TypesAndrew Elliott, Jian Zhang, Qing Zhang, et al.
Cancer Gene Therapy|August 22, 2024
Mesothelin expression correlates with elevated inhibitory immune activity in patients with colorectal cancerMidhun Malla, Sachin Kumar Deshmukh, Sharon Wu, et al.
Cell Chemical Biology|April 2, 2019
Translocation of a Cell Surface Spliceosomal Complex Induces Alternative Splicing Events and Lymphoma Cell NecrosisSonal S Tonapi, Vaishali Pannu, Janet E Duncan, et al.
Translational Oncology|July 29, 2023
Pan-tumor survey of RET fusions as detected by next-generation RNA sequencing identified RET fusion positive colorectal carcinoma as a unique molecular subsetMisako Nagasaka, Danielle Brazel, Yasmine Baca, et al.
Gynecologic Oncology|February 19, 2025
Exploring the differences between BRCA mutated and HRwild-type high grade serous ovarian cancer: A multiomic analysisAyesha B Alvero, Sharon Wu, Alex Farrell, et al.
JAMA Network Open|March 18, 2026
An AI Approach to Differentiating Lung Squamous Cell Carcinoma From Metastases of Other OriginsMark G Evans, Jennifer R Ribeiro, Todd Maney, et al.
NPJ Precision Oncology|June 15, 2026
Optimization of first-line treatment selection in advanced pancreatic adenocarcinoma using artificial intelligenceSebastian Cole, Paul Campitelli, Brian Grieb, et al.
Nucleic Acids Research|January 29, 2020
ADAPT identifies an ESCRT complex composition that discriminates VCaP from LNCaP prostate cancer cell exosomesTassilo Hornung, Heather A O'Neill, Stephen C Logie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2024
Differential Responses to Immune Checkpoint Inhibitors are Governed by Diverse Mismatch Repair Gene AlterationsMoh'd M Khushman, Michael D Toboni, Joanne Xiu, et al.
Cancer Cell|November 22, 2024
Mutation burden and anti-PD-1 outcomes are not universally associated with immune cell infiltration or lymphoid activationDavid Hsiehchen, Andrew Elliott, Joanne Xiu, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
The Journal of Molecular Diagnostics : JMD|September 25, 2021
Predicted Immunogenicity of CDK12 Biallelic Loss-of-Function Tumors Varies across Cancer TypesAndrew Elliott, Jian Zhang, Qing Zhang, et al.
Cancer Gene Therapy|August 22, 2024
Mesothelin expression correlates with elevated inhibitory immune activity in patients with colorectal cancerMidhun Malla, Sachin Kumar Deshmukh, Sharon Wu, et al.
Cell Chemical Biology|April 2, 2019
Translocation of a Cell Surface Spliceosomal Complex Induces Alternative Splicing Events and Lymphoma Cell NecrosisSonal S Tonapi, Vaishali Pannu, Janet E Duncan, et al.
Translational Oncology|July 29, 2023
Pan-tumor survey of RET fusions as detected by next-generation RNA sequencing identified RET fusion positive colorectal carcinoma as a unique molecular subsetMisako Nagasaka, Danielle Brazel, Yasmine Baca, et al.
Gynecologic Oncology|February 19, 2025
Exploring the differences between BRCA mutated and HRwild-type high grade serous ovarian cancer: A multiomic analysisAyesha B Alvero, Sharon Wu, Alex Farrell, et al.
JAMA Network Open|March 18, 2026
An AI Approach to Differentiating Lung Squamous Cell Carcinoma From Metastases of Other OriginsMark G Evans, Jennifer R Ribeiro, Todd Maney, et al.
NPJ Precision Oncology|June 15, 2026
Optimization of first-line treatment selection in advanced pancreatic adenocarcinoma using artificial intelligenceSebastian Cole, Paul Campitelli, Brian Grieb, et al.
Nucleic Acids Research|January 29, 2020
ADAPT identifies an ESCRT complex composition that discriminates VCaP from LNCaP prostate cancer cell exosomesTassilo Hornung, Heather A O'Neill, Stephen C Logie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2024
Differential Responses to Immune Checkpoint Inhibitors are Governed by Diverse Mismatch Repair Gene AlterationsMoh'd M Khushman, Michael D Toboni, Joanne Xiu, et al.
Cancer Cell|November 22, 2024
Mutation burden and anti-PD-1 outcomes are not universally associated with immune cell infiltration or lymphoid activationDavid Hsiehchen, Andrew Elliott, Joanne Xiu, et al.
Pageof 9